Gilpin Wealth Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$691 Hold
15
– – ﹤0.01% 751
2026
Q2
$881 Buy
15
+5
+50% +$210 ﹤0.01% 530
2026
Q1
$323 Hold
10
– – ﹤0.01% 748
2025
Q4
$421 Buy
+10
New +$403 ﹤0.01% 480

Other funds holding VCYT

Gilpin Wealth Management's VCYT Position: Q3 2026 in Review

Gilpin Wealth Management held its Veracyte (VCYT) position steady in Q3 2026 at 15 shares worth $691. The position accounts for ﹤0.01% of the portfolio, ranked #751.

Gilpin Wealth Management first reported a position in VCYT in Q4 2025 and has held it in 4 quarters since. The position peaked at $881 in Q2 2026. 11 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Gilpin Wealth Management held 15 shares of Veracyte worth $691 as of Q3 2026.
  • Gilpin Wealth Management left its Veracyte share count unchanged in Q3 2026.
  • Veracyte made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #751 holding.
  • Gilpin Wealth Management first reported a position in Veracyte in Q4 2025 and has held it in 4 quarters since.
  • Gilpin Wealth Management's Veracyte position peaked at $881 in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.